The standardized mortality rate for bladder malignant neoplasms in Japan is forecasted to remain constant at 6.6 per 100,000 men from 2024 to 2028. This stability indicates no anticipated year-on-year variation, maintaining the level that stood in 2023. With no changes predicted annually or over the forecasted five-year period, the compound annual growth rate is zero percent.
For future trends, it would be prudent to watch for any medical advancements or interventions that could impact bladder cancer mortality, shifts in smoking prevalence, as smoking is a risk factor, and government health policies that might affect early detection and treatment advances.
